AST-120 (Kremezin®) initiated in early stage chronic kidney disease stunts the progression of renal dysfunction in type 2 diabetic subjects
Kazunori Konishi, Shigeru Nakano, Shin-ichi Tsuda, Atsushi Nakagawa, Toshikazu Kigoshi, Daisuke KoyaVolume:
81
Year:
2008
Language:
english
Pages:
316
DOI:
10.1016/j.diabres.2008.04.024
File:
PDF, 375 KB
english, 2008